Theory 03/Virology & Immunity /Microbiome theory/3 min
The Virome Sets Immune Tone
The hygiene hypothesis counts bacteria. The most abundant biological entities at the mucosa are not bacteria.
Chronic bacteriophage exposure calibrates mucosal immune tone, so virome diversity predicts allergic disease better than bacterial diversity does, and the hygiene effect is substantially a loss of phage exposure.
01The evidence
- Children with allergic rhinitis show altered gut viromes, with enrichment of pro-inflammatory bacteriophages and depletion of fungal viruses, a pattern distinct from the bacterial changes usually reported, and cheap virome sequencing now allows the comparison to be made alongside standard 16S surveys.Microbiology Spectrum, 2026
02The tension
The hygiene hypothesis has been tested mostly through bacterial diversity, and the results are inconsistent: some studies find the expected association, others find none. Meanwhile the virome, which outnumbers bacteria at mucosal surfaces, is usually not measured at all.
03The theory
Phages are not passive passengers. They lyse bacteria, releasing nucleic acids and proteins that stimulate pattern recognition receptors, and they traffic across mucosa in numbers that make them a continuous low-level stimulus. That stimulus is what sets the baseline tone of the mucosal immune system.
A diverse virome provides a broad, low-grade signal that keeps regulatory circuits calibrated. A depauperate virome removes that signal, and the system drifts toward a Th2-skewed default. This is the hygiene effect restated in terms of the most abundant antigen source rather than the most studied one.
The theory predicts that virome diversity will outperform bacterial diversity as a predictor of atopy, and that this will be most visible in early life, when the virome is being assembled. It also predicts a direction: pro-inflammatory phage enrichment should precede sensitisation rather than follow it.
The therapeutic implication is unusual. Phage therapy is being developed for infection, but a defined phage consortium given to infants at risk would be a different product with a different regulatory path, closer to a probiotic than to an antimicrobial.
04What this is not
The bacterial account counts taxa and predicts that more bacterial diversity is protective. This predicts that virome diversity is the better predictor and that the mechanism is receptor stimulation by phage particles rather than bacterial colonisation.
05Predictions
- P1Virome diversity should predict atopy better than bacterial diversity in the same samples, after controlling for antibiotics and diet.
- P2Phage transfer into colonised animals should shift sensitisation thresholds, while bacterial transfer at matched load should not.
- P3Germ-free animals colonised with a defined virome should show an intermediate immune tone between germ-free and conventionally housed.
06What would refute it
If virome diversity adds nothing to bacterial diversity in prospective cohorts, the virome is a marker rather than a cause.
07What it would change
It would add a viral arm to microbiome therapeutics and change what infant cohort studies sequence.
08Evidence base
- Alterations in the gut virome of children with allergic rhinitis — Microbiology Spectrumhttps://journals.asm.org/doi/full/10.1128/spectrum.03276-25